SELLAS Life Sciences Group, Inc. (SLS)
14.03
-0.13
(-0.92%)
USD |
NASDAQ |
Sep 03, 10:01
SELLAS Life Sciences Group Net Income (Annual) : -26.86M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -26.86M |
| December 31, 2024 | -30.88M |
| December 31, 2023 | -37.34M |
| December 31, 2022 | -41.30M |
| December 31, 2021 | -20.70M |
| December 31, 2020 | -16.76M |
| December 31, 2019 | -19.54M |
| December 31, 2018 | -28.16M |
| December 31, 2017 | -24.43M |
| December 31, 2016 | -17.68M |
| December 31, 2015 | -38.96M |
| Date | Value |
|---|---|
| December 31, 2014 | -36.61M |
| December 31, 2013 | -76.68M |
| December 31, 2012 | -33.32M |
| December 31, 2011 | -11.48M |
| December 31, 2010 | -11.99M |
| December 31, 2009 | -18.39M |
| December 31, 2008 | -14.37M |
| December 31, 2007 | -10.99M |
| December 31, 2006 | -2.405M |
| December 31, 2005 | -2.209M |
| December 31, 2004 | -3.272M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Savara, Inc. | -118.84M |
| Lite Strategy, Inc. | -15.94M |
| AbbVie, Inc. | 4.193B |
| Marker Therapeutics, Inc. | -12.16M |
| Rezolute, Inc. | -74.41M |